V
Velano Vascular
Needle-free blood collection device for inpatient care
About Velano Vascular
Velano Vascular, founded in 2012 by Eric M. Stone and Dr. Pitamber Devgon, developed a medical device to transform inpatient blood draws. The company's core product, PIVO (Push-in, Twist-off), is a needle-free blood collection device that attaches to an existing peripheral intravenous (IV) catheter, enabling practitioners to collect high-quality blood samples without a separate needle stick for each draw. This process aims to reduce patient pain and anxiety, particularly for those with difficult venous access or who require frequent testing, while also increasing practitioner safety.
The concept for Velano Vascular originated from the collaboration between Stone, a patient advocate diagnosed with Crohn's Disease as a teenager, and Dr. Devgon, an internal medicine physician. Stone's personal experience with frequent medical procedures and his background in healthcare marketing and business development, combined with Dr. Devgon's clinical perspective, drove the creation of a more compassionate approach to vascular access. Before co-founding Velano, Stone held positions at Abbott Laboratories and was a founding member of Model N's Life Sciences division. Dr. Devgon, the inventor of the patented technology, previously worked in venture capital at Safeguard Scientifics, focusing on medical device investments.
Velano Vascular's business model focused on selling the single-use, FDA-cleared PIVO device to hospitals and health systems. The company demonstrated the device's value by highlighting improved patient satisfaction, reduced procedural risks, and potential cost efficiencies. By making the existing IV line a reliable access point for blood collection, PIVO aimed to establish a "one-stick hospital stay" as a new standard of care. The company raised significant funding, over $51 million, from investors including First Round Capital, Kapor Capital, and major health systems like Intermountain Healthcare. In July 2021, Becton, Dickinson and Company (BD), a global medical technology company, acquired Velano Vascular to integrate the PIVO technology into its portfolio of vascular access and blood collection solutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2012
- Headquarters
- San Francisco, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 60.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Risk Management, Cardiology and cardiovascular, Health Diagnostics, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jul 2021 | $0 | — | BD | — |
| EARLY VCOther financing | Dec 2019 | $15M | $60M | Undisclosed | — |
Growth signals
Latest recorded traffic for Velano Vascular is 170 monthly website visits, down 77.9% over the last three months. Velano Vascular's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
First Round Capital
Kapor Capital
Safeguard Scientifics
Edward Ludwig
The Children's Hospital of Philadelphia
Griffin Hospital
Sutter Health
Intermountain Healthcare
Marc Benioff
Other known investors1 additional known investor
BD
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Velano Vascular on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Velano Vascular’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







